• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Orthopedic Surgery

Joint fusion superior to watchful waiting for hallux rigidus 

byAdrian WongandMichaela Dowling
August 10, 2026
in Orthopedic Surgery
Reading Time: 3 mins read
Uninterrupted warfarin therapy safe for endovascular procedures
Share on FacebookShare on Twitter

1. In this randomized controlled trial, arthrodesis significantly reduced walking-related pain compared with watchful waiting in adults aged 40 years or older with hallux rigidus.

2. Arthrodesis also improved pain at rest and was associated with lower analgesic use.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Hallux rigidus, or osteoarthritis of the first metatarsophalangeal joint (MTPJ) at the base of the great toe, is a common degenerative joint disorder. Joint-space narrowing, osteophyte formation, and restricted dorsiflexion can lead to pain, difficulty walking, and discomfort with footwear. Evidence supporting conservative management remains limited, while recommendations for surgical intervention have largely been based on observational studies and case series. This study evaluated whether MTPJ arthrodesis, the gold-standard surgical treatment for hallux rigidus, is superior to watchful waiting. At follow-up, patients who underwent arthrodesis reported significantly less walking-related pain than those managed with watchful waiting. Arthrodesis was also associated with reduced pain at rest and lower analgesic use. No major adverse events or reoperations were reported. Notably, a substantial proportion of participants initially assigned to watchful waiting ultimately elected to undergo arthrodesis during the study period. The generalizability of these findings is limited by the study’s single-centre design, potential selection bias, lack of blinding, and exclusion of patients with conditions such as increased hallux valgus angle, rheumatoid arthritis, or prior foot and ankle trauma. Nevertheless, this trial provides higher-quality evidence supporting arthrodesis as an effective treatment option for adults with hallux rigidus who are seeking relief from walking-related pain.

Click to read this study in AIM

Relevant Reading: Functional Outcomes Following First Metatarsophalangeal Arthrodesis

RELATED REPORTS

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

In-Depth [randomized controlled trial]: This randomized controlled trial evaluated whether first MTPJ arthrodesis was superior to watchful waiting for painful hallux rigidus. Eligible participants were adults aged 40 years or older with walking-related pain rated at least 4/10 for more than 1 year and radiographic evidence of first MTPJ osteoarthritis (Coughlin-Shurnas grades I–III). Patients with hallux valgus angle greater than 15°, rheumatoid arthritis, peripheral neuropathy, or poorly controlled diabetes were excluded. The primary outcome was walking-related pain at 12 months, measured on a 0-10 numerical rating scale (NRS). Secondary outcomes included pain at rest, satisfaction, disability, foot function, quality of life, and use of analgesics and orthoses. Of 165 patients screened, 147 (89%) were eligible and 90 (61%) consented to participate. Participants were randomized to arthrodesis (n = 45) or watchful waiting (n = 45), with follow-up completed by 89 of 90 participants (99%). The mean age was 58 years, the median symptom duration was 60 months, 57% were women, and the median baseline walking pain score was 6/10. At 12 months, mean walking-related pain was 1.3 in the arthrodesis group compared with 5.7 in the watchful waiting group, corresponding to an adjusted mean difference of -5.0 points (95% confidence interval [CI], -6.1 to -3.9), substantially exceeding the minimal important difference (MID) of 1.7 points. Pain at rest was also lower following arthrodesis (0.6 vs. 3.6; adjusted mean difference, -3.5 [95% CI, -4.7 to -2.4]), again exceeding the MID. Most functional outcomes, including Manchester-Oxford Foot Questionnaire domains, also favored arthrodesis. No serious adverse events or reoperations occurred, although six minor adverse events were reported after surgery. Notably, 29 of 45 participants (64%) initially assigned to watchful waiting ultimately opted for arthrodesis during follow-up. Sensitivity analyses yielded similar results. Overall, arthrodesis was superior to watchful waiting for improving pain, function, and quality of life in adults with hallux rigidus.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: arthrodesishallux rigidusjoint painjoint surgeryosteoarthritisosteoarthritis pain
Previous Post

2 Minute Medicine Rewind August 10, 2026

Next Post

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

RelatedReports

Amyloid may cause distant cerebral hypometabolism in Alzheimer’s
Psychiatry

Glucosamine Linked to Faster Alzheimer’s Progression in Patients with Mild Cognitive Impairment

September 4, 2026
Physical therapy reduces pain in adults with knee osteoarthritis
Chronic Disease

Selective serotonin reuptake inhibitors may reduce risk of total joint arthroplasty in osteoarthritis

May 21, 2026
#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis
StudyGraphics

#VisualAbstract: Personalised Gait Retraining is an Effective Non-Surgical Treatment for Medial Compartment Knee Osteoarthritis

August 25, 2025
Shorter hospital stays after hip fracture linked to greater risk of short-term death
Orthopedic Surgery

Very-low-calorie diets versus exercise alone for the treatement of hip osteoarthritis

August 4, 2025
Next Post
Postextubation administration of high-flow oxygen leads to reduced reintubation and respiratory failure

Bougie-guided and stylet-guided intubation may have similar success rate in the intubation of trauma patients

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Surgery is associated with an increased quality of life in women with endometriosis

Prevalence of hypertension among adolescents varies by race and BMI

A health coaching intervention may improve blood pressure control in postpartum women

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • FDA-cleared AI devices rarely have patient outcome data
  • Apixaban (Eliquis) is associated with reduced rates of ischemic stroke and bleeding in patients with atrial fibrillation and advanced chronic kidney disease compared with warfarin (Coumadin)
  • Artificial intelligence based clinical exam training significantly improved medical students’ standardized clinical exam performance
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.